# Antithymocyte Globulin and Cyclosporine to Treat Myelodysplasia

> **NCT00005937** · PHASE2 · COMPLETED · sponsor: **Neal Young, M.D.** · enrollment: 42 (actual)

## Conditions studied

- Myelodysplastic Syndrome

## Interventions

- **DRUG:** Antithymocyte globulin
- **DRUG:** Cyclosporine

## Key facts

- **NCT ID:** NCT00005937
- **Lead sponsor:** Neal Young, M.D.
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-06
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2014-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005937, "Antithymocyte Globulin and Cyclosporine to Treat Myelodysplasia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00005937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*